Clinical Trial Update: Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) [Phase 2]

View source ↗

Summary

Phase 2 trial of pacritinib before transplantation in myeloproliferative neoplasms was terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Disease
• Myeloproliferative Neoplasm

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloproliferative Diseases | Phase 2 | Status: TERMINATED | Results posted: 2018-10-05